^
    Back
    Association details:
    Biomarker:miR-572 overexpression
    Cancer:Prostate Cancer
    Drug:docetaxel (Tubulin polymerization promoter, Microtubule stabilizer)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: D – Preclinical
    Source:
    J Int Med Res
    Title:

    The role of microRNA-572 in the proliferation and chemotherapeutic treatment of prostate cancer

    Published date:
    05/27/2021
    Excerpt:
    The proliferation rates of LNCaP and PC-3 PCa cells were studied using MTT assays….Overexpression of miR-572 decreased sensitivity of PCa cells to docetaxel treatment by reducing docetaxel-induced apoptosis
    DOI:
    10.1177/03000605211014363